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A 70-year-old woman presented with a 2-week history of facial eruption. She was treated with corticosteroid, on the basis of a diagnosis of allergic contact dermatitis, which improved her condition. However, it recurred after 1 year. She did not complain about any subjective photosensitivity or hypersensitivity to mosquito bites. Physical examination revealed multiple erythematous papulopustules with ulcers and crusts on the face, accompanied by edema on both cheeks and eyelids (Fig. 1) . She was otherwise healthy, except for having had cryptogenic liver cirrhosis 7 years previously. Histopathological examination was performed on the forehead. Small to medium-sized atypical lymphocytes infiltrated around the perivascular and periadnexal spaces in the entire dermis ( Fig. 2A, B) . These atypical cells were positive for CD2, CD3, CD5, and T-cell intercellular antigen-1, and focally positive for CD8 ( is characterized by an edematous, crusted papulovesicular eruption similar to HV [1] [2] [3] [4] . Unlike HV, however, it could also occur in non-sun-exposed areas, and is accompanied by fever, lymphadenopathy, or hepatosplenomegaly [1] [2] [3] [4] .
Because HV-like lymphoma could occur in non-sun-exposed areas and is accompanied by systemic symptoms, it can be confused with HV-like eruption. However, as recent studies revealed that most lesions contain monoclonal TCR rearrangement, the World Health Organization classification system newly categorized it as one of the EBV-associated lymphoproliferative disorders of childhood in 2008 5 . These three disease categories were related to EBV A 38-year-old man was referred to our hospital with a left renal mass and multiple paraspinal and rib masses. The diagnosis was clear cell renal cell carcinoma with multiple bone metastases with soft tissue formation, and multiple lymph node metastases in both histological and radiological evaluations. He was treated with 800 mg pazopanib once daily. During the treatment, he began to notice a gradual increase in scalp hair loss and a change in his hair texture. Before starting the therapy, he had coarse, black hair (Fig. 1A) , and denied ever dying his hair or having a history of alopecia. By the fifth month of therapy, nearly all of his scalp hair had turned white, whereas his other body hair had changed little (Fig. 1B, C) . In addition, his hair texture changed from coarse to fine. The therapy was discontinued after 8 months because of disease progression, and the new hair growth was pigmented. On the basis of these findings, we concluded that the hair de-
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